A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain
Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architecture...
Saved in:
| Published in | Alzheimer's research & therapy Vol. 11; no. 1; pp. 71 - 16 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
09.08.2019
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution.
We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses.
We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles.
We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. |
|---|---|
| AbstractList | Abstract Background Alzheimer’s disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution. Methods We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses. Results We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles. Conclusion We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. Background Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution. Methods We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses. Results We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles. Conclusion We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. Keywords: PSEN1, Single-nuclei RNA-seq, Alzheimer's disease, Web-based brain molecular atlas Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution. We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses. We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles. We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution.BACKGROUNDAlzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution.We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses.METHODSWe generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses.We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles.RESULTSWe identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles.We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available.CONCLUSIONWe propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD brain changes in cell proportion and gene expression using single-cell resolution. We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable further analyses. We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes, oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of disease-associated microglia (DAM) discovered in mouse models. We also determined that when analyzing human single-nuclei data, it is critical to control for biases introduced by donor-specific expression profiles. We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make this unique single-nuclei molecular atlas publicly available. |
| ArticleNumber | 71 |
| Audience | Academic |
| Author | Del-Aguila, Jorge L. Bergmann, Kristy Budde, John P. Fernandez, Maria Victoria Wang, Fengxian Davenport, Richard Dube, Umber Perrin, Richard J. Ibanez, Laura Bradley, Joseph Holtzman, David M. Morris, John C. Benitez, Bruno A. Cruchaga, Carlos Harari, Oscar Dougherty, Joseph Li, Zeran Mihindukulasuriya, Kathie A. |
| Author_xml | – sequence: 1 givenname: Jorge L. surname: Del-Aguila fullname: Del-Aguila, Jorge L. – sequence: 2 givenname: Zeran surname: Li fullname: Li, Zeran – sequence: 3 givenname: Umber surname: Dube fullname: Dube, Umber – sequence: 4 givenname: Kathie A. surname: Mihindukulasuriya fullname: Mihindukulasuriya, Kathie A. – sequence: 5 givenname: John P. surname: Budde fullname: Budde, John P. – sequence: 6 givenname: Maria Victoria surname: Fernandez fullname: Fernandez, Maria Victoria – sequence: 7 givenname: Laura surname: Ibanez fullname: Ibanez, Laura – sequence: 8 givenname: Joseph surname: Bradley fullname: Bradley, Joseph – sequence: 9 givenname: Fengxian surname: Wang fullname: Wang, Fengxian – sequence: 10 givenname: Kristy surname: Bergmann fullname: Bergmann, Kristy – sequence: 11 givenname: Richard surname: Davenport fullname: Davenport, Richard – sequence: 12 givenname: John C. surname: Morris fullname: Morris, John C. – sequence: 13 givenname: David M. surname: Holtzman fullname: Holtzman, David M. – sequence: 14 givenname: Richard J. surname: Perrin fullname: Perrin, Richard J. – sequence: 15 givenname: Bruno A. surname: Benitez fullname: Benitez, Bruno A. – sequence: 16 givenname: Joseph surname: Dougherty fullname: Dougherty, Joseph – sequence: 17 givenname: Carlos surname: Cruchaga fullname: Cruchaga, Carlos – sequence: 18 givenname: Oscar orcidid: 0000-0002-2635-6975 surname: Harari fullname: Harari, Oscar |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31399126$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Ul1rFDEUDVKx7eoP8EUGBPFlau4kk48XYalfhaog9Tlkkju7KbNJncxI--_NurXsikgeEs495-Te5JySo5giEvIc6BmAEm8yMNBtTUHXtG14ffuInIBsVa1Bs6O98zE5zfmaUiEaxZ-QYwZMa2jECblaVjnE1YB1nN2Aofr2pSD4Y8boCl7lafZ3Veqrzxg9DsHGykZf5Zs0Wh9ctXxXhVhNa6zW86YUu9GG-JQ87u2Q8dn9viDfP7y_Ov9UX379eHG-vKxdK9hUo-eMUQ-AvPNMdYx7UBK86ngLtHWqQRSNZ5JxSZvGoRa8kVwjk7pwkS3Ixc7XJ3ttbsawseOdSTaY30AaV8aOUyhzGQfWt1JpTnvGO9crpa1FbqFFyhyF4vV253Uzdxv0DuM02uHA9LASw9qs0k8jhNIgZTF4fW8wpvJ8eTKbkB0Og42Y5myaRoLigpfvWJCXO-rKltZC7FNxdFu6WbZaCEpVu-3o7B-ssjxugitJ6EPBDwSv9gRrtMO0zmmYp5BiPiS-2J_1Ycg_sSgE2BHcmHIesX-gADXb6Jld9EyJntlGz9wWjfxL48Jkt3eXtsPwH-UvFj7aJA |
| CitedBy_id | crossref_primary_10_1093_brain_awac080 crossref_primary_10_1007_s10571_021_01159_3 crossref_primary_10_1186_s13073_021_00878_y crossref_primary_10_1002_advs_202410098 crossref_primary_10_1097_MD_0000000000040551 crossref_primary_10_2967_jnumed_121_263200 crossref_primary_10_1186_s41232_023_00277_3 crossref_primary_10_3390_bioengineering8110166 crossref_primary_10_1016_j_arr_2021_101444 crossref_primary_10_1038_s41593_022_01222_2 crossref_primary_10_3389_fnagi_2021_690372 crossref_primary_10_1016_j_neuron_2023_01_016 crossref_primary_10_3389_fncel_2021_772011 crossref_primary_10_1016_j_molmed_2020_09_001 crossref_primary_10_1002_glia_24633 crossref_primary_10_1002_adhm_202304180 crossref_primary_10_1002_ctd2_95 crossref_primary_10_1084_jem_20202717 crossref_primary_10_1186_s40478_022_01342_7 crossref_primary_10_1007_s12264_022_01013_6 crossref_primary_10_1007_s11427_023_2360_3 crossref_primary_10_3389_fimmu_2023_1271466 crossref_primary_10_1080_09168451_2020_1714420 crossref_primary_10_1111_acel_13606 crossref_primary_10_1038_s41598_020_76784_x crossref_primary_10_1007_s11011_025_01538_5 crossref_primary_10_1126_scitranslmed_aax3519 crossref_primary_10_1038_s41586_021_03489_0 crossref_primary_10_1016_j_it_2020_07_005 crossref_primary_10_1016_j_tins_2021_12_004 crossref_primary_10_1016_j_it_2020_07_006 crossref_primary_10_1016_j_isci_2020_101556 crossref_primary_10_1016_j_cell_2023_10_005 crossref_primary_10_1038_s41467_023_37437_5 crossref_primary_10_1111_jnc_16002 crossref_primary_10_1038_s41586_022_04587_3 crossref_primary_10_3389_fncel_2023_1208122 crossref_primary_10_1038_s41593_023_01356_x crossref_primary_10_3389_fcell_2022_884748 crossref_primary_10_1101_gr_278253_123 crossref_primary_10_3390_cells12071051 crossref_primary_10_4049_jimmunol_2300007 crossref_primary_10_1186_s13024_021_00476_x crossref_primary_10_1186_s40478_022_01328_5 crossref_primary_10_3389_fnmol_2021_651355 crossref_primary_10_1038_s41380_024_02456_1 crossref_primary_10_1016_j_pharmthera_2024_108606 crossref_primary_10_1016_j_celrep_2023_112196 crossref_primary_10_1016_j_neubiorev_2021_12_023 crossref_primary_10_1016_j_neuron_2021_07_004 crossref_primary_10_3389_fphar_2021_766082 crossref_primary_10_1038_s41577_023_00907_4 crossref_primary_10_26508_lsa_202403080 crossref_primary_10_1016_j_molmed_2023_01_002 crossref_primary_10_1002_alz_12012 crossref_primary_10_14336_AD_2023_0505 crossref_primary_10_3389_fncel_2022_1025012 crossref_primary_10_3390_genes12081247 crossref_primary_10_1038_s41582_021_00578_6 crossref_primary_10_1038_s41582_023_00809_y crossref_primary_10_1007_s10439_020_02507_y crossref_primary_10_1016_j_cell_2020_06_038 crossref_primary_10_1371_journal_ppat_1009665 crossref_primary_10_3389_fnsyn_2021_773590 crossref_primary_10_26508_lsa_202000874 crossref_primary_10_1038_s41593_021_00886_6 crossref_primary_10_1080_15476286_2020_1870362 crossref_primary_10_1093_hmg_ddaa038 crossref_primary_10_1016_j_celrep_2020_107843 crossref_primary_10_1007_s11427_023_2473_x crossref_primary_10_1016_j_pneurobio_2021_102173 crossref_primary_10_1186_s40478_020_01083_5 crossref_primary_10_1002_alz_12389 crossref_primary_10_1016_j_neuron_2023_05_006 crossref_primary_10_1016_j_neuron_2022_06_021 crossref_primary_10_1093_braincomms_fcaa112 crossref_primary_10_1016_j_ibmb_2023_104043 crossref_primary_10_1016_j_psc_2025_01_002 crossref_primary_10_1080_19768354_2022_2110937 crossref_primary_10_1016_j_cell_2023_01_002 crossref_primary_10_1016_j_celrep_2020_108189 crossref_primary_10_1038_s41597_024_03485_9 crossref_primary_10_1002_cpmo_66 crossref_primary_10_1038_s41588_021_00894_z crossref_primary_10_1038_s41467_022_34412_4 crossref_primary_10_1002_adfm_201909146 crossref_primary_10_1111_nan_12642 crossref_primary_10_1186_s13024_025_00798_0 crossref_primary_10_1016_j_neuron_2022_03_008 crossref_primary_10_1038_s41598_024_71888_0 crossref_primary_10_1016_j_xcrm_2023_101175 crossref_primary_10_1146_annurev_immunol_101921_035222 crossref_primary_10_1038_s41593_024_01600_y crossref_primary_10_3390_ijms25063090 crossref_primary_10_1016_j_ajhg_2021_12_014 crossref_primary_10_1016_j_isci_2020_101769 crossref_primary_10_1038_s41467_024_48926_6 crossref_primary_10_1016_j_isci_2021_102357 crossref_primary_10_3390_biom13020313 crossref_primary_10_1016_j_semcdb_2023_06_005 crossref_primary_10_1186_s13578_023_01120_5 |
| Cites_doi | 10.1038/nmeth.4402 10.1038/s41467-018-03405-7 10.1038/ncomms14049 10.1038/nbt.4096 10.1038/nrn2459 10.1038/s41586-018-0654-5 10.1186/s13073-018-0551-4 10.1146/annurev-cellbio-100109-104117 10.1016/j.molmed.2005.02.009 10.1016/j.cell.2018.07.028 10.1371/journal.pone.0209648 10.1038/nn.2207 10.1093/bioinformatics/btv088 10.1016/j.molcel.2017.11.017 10.1152/physrev.2001.81.2.741 10.1002/glia.22683 10.1016/j.ejphar.2004.02.046 10.1126/science.aaf1204 10.1126/science.aao4827 10.1016/j.celrep.2017.03.004 10.1093/nar/gkw430 10.1038/nature10110 10.1126/science.aad6469 10.1038/s41467-018-02926-5 10.1038/s41598-018-27293-5 10.1016/j.celrep.2017.12.066 10.1126/science.aat8464 10.18637/jss.v0.32.i06 10.1016/j.neubiorev.2011.06.009 10.1073/pnas.1319700110 10.3233/JAD-122299 10.1038/s41593-018-0216-z 10.1039/C5IB00191A 10.1038/nn.3898 10.1038/nbt.4038 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 BioMed Central Ltd. The Author(s). 2019 |
| Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: The Author(s). 2019 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1186/s13195-019-0524-x |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1758-9193 |
| EndPage | 16 |
| ExternalDocumentID | oai_doaj_org_article_c1ad578940f34bcf889aae4a15e03c01 PMC6689177 A596600851 31399126 10_1186_s13195_019_0524_x |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG057777 – fundername: NIH HHS grantid: R01AG057777 – fundername: NIA NIH HHS grantid: P50 AG005681 – fundername: NIA NIH HHS grantid: P01 AG003991 – fundername: NIA NIH HHS grantid: P01 AG026276 – fundername: ; grantid: R01AG057777 |
| GroupedDBID | --- 0R~ 23M 2WC 53G 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACJQM ACUHS ADBBV ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ IAO IEA IHR IHW INH INR ITC KQ8 M1P M~E O5R O5S O9- OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SBL SOJ TR2 TUS UKHRP -56 -5G -BR 3V. ACRMQ ADINQ C24 NPM PMFND 7X8 PPXIY 5PM PJZUB PUEGO |
| ID | FETCH-LOGICAL-c563t-ed4330d11e4bd38b34d1871d8b45105c82ee62d37347022ce9642749e37934de3 |
| IEDL.DBID | DOA |
| ISSN | 1758-9193 |
| IngestDate | Wed Aug 27 01:31:19 EDT 2025 Thu Aug 21 14:32:52 EDT 2025 Fri Jul 11 01:25:26 EDT 2025 Tue Jun 17 20:51:30 EDT 2025 Tue Jun 10 20:24:50 EDT 2025 Thu May 22 21:21:02 EDT 2025 Thu Jan 02 22:58:15 EST 2025 Thu Apr 24 22:49:46 EDT 2025 Tue Jul 01 02:38:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Single-nuclei RNA-seq Web-based brain molecular atlas PSEN1 Alzheimer’s disease |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c563t-ed4330d11e4bd38b34d1871d8b45105c82ee62d37347022ce9642749e37934de3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2635-6975 |
| OpenAccessLink | https://doaj.org/article/c1ad578940f34bcf889aae4a15e03c01 |
| PMID | 31399126 |
| PQID | 2271846419 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c1ad578940f34bcf889aae4a15e03c01 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6689177 proquest_miscellaneous_2271846419 gale_infotracmisc_A596600851 gale_infotracacademiconefile_A596600851 gale_healthsolutions_A596600851 pubmed_primary_31399126 crossref_primary_10_1186_s13195_019_0524_x crossref_citationtrail_10_1186_s13195_019_0524_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-08-09 |
| PublicationDateYYYYMMDD | 2019-08-09 |
| PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-09 day: 09 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Alzheimer's research & therapy |
| PublicationTitleAlternate | Alzheimers Res Ther |
| PublicationYear | 2019 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | I Voineagu (524_CR27) 2011; 474 Daifeng Wang (524_CR28) 2018; 362 BA Friedman (524_CR38) 2018; 22 E Bruner (524_CR29) 2013; 35 WV Li (524_CR20) 2018; 9 Z Li (524_CR4) 2018; 10 X Qiu (524_CR7) 2017; 14 AE Jaffe (524_CR24) 2015; 18 Z Ji (524_CR22) 2016; 44 DJ Selkoe (524_CR3) 2001; 81 MC Oldham (524_CR26) 2008; 11 B De Strooper (524_CR2) 2010; 26 524_CR6 AT McKenzie (524_CR18) 2018; 8 MJ Gandal (524_CR23) 2018; 359 TE Bakken (524_CR33) 2018; 13 A Butler (524_CR36) 2018; 36 BB Lake (524_CR5) 2016; 352 Heather C. Rice (524_CR19) 2019; 363 C Xu (524_CR13) 2015; 31 B Tasic (524_CR16) 2018; 563 RV Grindberg (524_CR9) 2013; 110 KW Kelley (524_CR25) 2018; 21 R Chen (524_CR14) 2017; 18 524_CR17 HI Jacobs (524_CR31) 2012; 36 P Hu (524_CR15) 2017; 68 CE Shannon (524_CR21) 1997; 14 BB Lake (524_CR34) 2018; 36 524_CR12 M Olah (524_CR39) 2018; 9 R Cabeza (524_CR30) 2008; 9 S Herculano-Houzel (524_CR37) 2014; 62 Arpiar Saunders (524_CR11) 2018; 174 FM LaFerla (524_CR1) 2005; 11 524_CR10 J Lindeboom (524_CR32) 2004; 490 J Wang (524_CR35) 2015; 7 GX Zheng (524_CR8) 2017; 8 |
| References_xml | – volume: 14 start-page: 979 issue: 10 year: 2017 ident: 524_CR7 publication-title: Nat Methods doi: 10.1038/nmeth.4402 – volume: 9 start-page: 997 issue: 1 year: 2018 ident: 524_CR20 publication-title: Nat Commun doi: 10.1038/s41467-018-03405-7 – volume: 8 year: 2017 ident: 524_CR8 publication-title: Nat Commun doi: 10.1038/ncomms14049 – volume: 36 start-page: 411 issue: 5 year: 2018 ident: 524_CR36 publication-title: Nat Biotechnol doi: 10.1038/nbt.4096 – volume: 9 start-page: 613 issue: 8 year: 2008 ident: 524_CR30 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2459 – volume: 563 start-page: 72 issue: 7729 year: 2018 ident: 524_CR16 publication-title: Nature. doi: 10.1038/s41586-018-0654-5 – volume: 10 start-page: 43 issue: 1 year: 2018 ident: 524_CR4 publication-title: Genome Med doi: 10.1186/s13073-018-0551-4 – volume: 26 start-page: 235 year: 2010 ident: 524_CR2 publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev-cellbio-100109-104117 – volume: 11 start-page: 170 issue: 4 year: 2005 ident: 524_CR1 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2005.02.009 – volume: 174 start-page: 1015-1030.e16 issue: 4 year: 2018 ident: 524_CR11 publication-title: Cell doi: 10.1016/j.cell.2018.07.028 – volume: 13 issue: 12 year: 2018 ident: 524_CR33 publication-title: PLoS One doi: 10.1371/journal.pone.0209648 – volume: 11 start-page: 1271 issue: 11 year: 2008 ident: 524_CR26 publication-title: Nat Neurosci doi: 10.1038/nn.2207 – volume: 31 start-page: 1974 issue: 12 year: 2015 ident: 524_CR13 publication-title: Bioinformatics. doi: 10.1093/bioinformatics/btv088 – volume: 68 start-page: 1006 issue: 5 year: 2017 ident: 524_CR15 publication-title: Mol Cell doi: 10.1016/j.molcel.2017.11.017 – volume: 14 start-page: 306 issue: 4 year: 1997 ident: 524_CR21 publication-title: MD Comput – volume: 81 start-page: 741 issue: 2 year: 2001 ident: 524_CR3 publication-title: Physiol Rev doi: 10.1152/physrev.2001.81.2.741 – ident: 524_CR17 – volume: 62 start-page: 1377 issue: 9 year: 2014 ident: 524_CR37 publication-title: Glia. doi: 10.1002/glia.22683 – volume: 490 start-page: 83 issue: 1–3 year: 2004 ident: 524_CR32 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2004.02.046 – volume: 352 start-page: 1586 issue: 6293 year: 2016 ident: 524_CR5 publication-title: Science. doi: 10.1126/science.aaf1204 – volume: 363 start-page: eaao4827 issue: 6423 year: 2019 ident: 524_CR19 publication-title: Science doi: 10.1126/science.aao4827 – ident: 524_CR6 – volume: 18 start-page: 3227 issue: 13 year: 2017 ident: 524_CR14 publication-title: Cell Rep doi: 10.1016/j.celrep.2017.03.004 – volume: 44 start-page: e117 issue: 13 year: 2016 ident: 524_CR22 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkw430 – volume: 474 start-page: 380 issue: 7351 year: 2011 ident: 524_CR27 publication-title: Nature. doi: 10.1038/nature10110 – volume: 359 start-page: 693 issue: 6376 year: 2018 ident: 524_CR23 publication-title: Science. doi: 10.1126/science.aad6469 – volume: 9 start-page: 539 issue: 1 year: 2018 ident: 524_CR39 publication-title: Nat Commun doi: 10.1038/s41467-018-02926-5 – volume: 8 start-page: 8868 issue: 1 year: 2018 ident: 524_CR18 publication-title: Sci Rep doi: 10.1038/s41598-018-27293-5 – volume: 22 start-page: 832 issue: 3 year: 2018 ident: 524_CR38 publication-title: Cell Rep doi: 10.1016/j.celrep.2017.12.066 – volume: 362 start-page: eaat8464 issue: 6420 year: 2018 ident: 524_CR28 publication-title: Science doi: 10.1126/science.aat8464 – ident: 524_CR12 doi: 10.18637/jss.v0.32.i06 – volume: 36 start-page: 297 issue: 1 year: 2012 ident: 524_CR31 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2011.06.009 – volume: 110 start-page: 19802 issue: 49 year: 2013 ident: 524_CR9 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1319700110 – volume: 35 start-page: 227 issue: 2 year: 2013 ident: 524_CR29 publication-title: J Alzheimers Dis doi: 10.3233/JAD-122299 – volume: 21 start-page: 1171 issue: 9 year: 2018 ident: 524_CR25 publication-title: Nat Neurosci doi: 10.1038/s41593-018-0216-z – volume: 7 start-page: 1466 issue: 11 year: 2015 ident: 524_CR35 publication-title: Integr Biol (Camb) doi: 10.1039/C5IB00191A – volume: 18 start-page: 154 issue: 1 year: 2015 ident: 524_CR24 publication-title: Nat Neurosci doi: 10.1038/nn.3898 – volume: 36 start-page: 70 issue: 1 year: 2018 ident: 524_CR34 publication-title: Nat Biotechnol doi: 10.1038/nbt.4038 – ident: 524_CR10 |
| SSID | ssj0066284 |
| Score | 2.5207655 |
| Snippet | Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting... Background Alzheimer's disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis heavily... Abstract Background Alzheimer’s disease (AD) is the most common form of dementia. This neurodegenerative disorder is associated with neuronal death and gliosis... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 71 |
| SubjectTerms | Advertising executives Alzheimer's disease Banking industry Banks (Finance) Best practices Biochemistry Brain Care and treatment Death Gene expression Gene mutation Genes Genetic aspects Genetic research Genetics Nervous system diseases Neurons PSEN1 RNA RNA sequencing Single-nuclei RNA-seq Tissue donation Web-based brain molecular atlas |
| Title | A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31399126 https://www.proquest.com/docview/2271846419 https://pubmed.ncbi.nlm.nih.gov/PMC6689177 https://doaj.org/article/c1ad578940f34bcf889aae4a15e03c01 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9wwDDdb-7KXsbFuy9beXBgMBqHxR2zn8XprKYUeo7Rwb8axHXZQcmW9Qv_8SnbuuDDYXvYYWwFHlizJkX4i5Ctvmeqk9yWPSpSSua5sJVYBV6rVXtSmSyBJV3N1cSsvF_Vip9UX5oRleODMuBPPXACpamTVCdn6zpjGuSgdq2MlfK7cApu3CabyGawUnLrDP0xm1MkDE9iTsMKCnZrL8mlkhRJY_59H8o5NGudL7hig8zfk9eA50mle8VvyIvbvyM2UYrB_F8segYmX9HoOIzk9GsZpQo-lq45e4VU3XmlQ1weKsawLS0-nP-iyp-AE0tSsj7bYMeKA3J6f3cwuyqFRQulrJdZlDFKIKjAWZRuEaYUMDAKhYFqJ_pM3PEbFg9BCarDZPjYQdWjZRAHaKUMU78lev-rjR0KFq7qGK3C5g5LRgTU3vtMxYhdN2ApTkGrDOOsHFHFsZnFnUzRhlM28tsBri7y2TwX5vn3lPkNo_I34FHdjS4jo12kAZMIOMmH_JRMF-YJ7aXMp6VaH7bRGLFJ0MgvyLVGgFsPyvRuKEYAJiIc1ojwcUYL2-dH08UZeLE5hylofV48PlnMw-1JJ1hTkQ5af7VcJ8LsbxlVB9EiyRp89numXvxL4t1IGImz96X_w6TN5xZNOYAbMIdlb_36MR-BjrdsJeakXekL2T8_mP6_haaZmk6Riz7NzJLk |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+single-nuclei+RNA+sequencing+study+of+Mendelian+and+sporadic+AD+in+the+human+brain&rft.jtitle=Alzheimer%27s+research+%26+therapy&rft.au=Del-Aguila%2C+Jorge+L.&rft.au=Li%2C+Zeran&rft.au=Dube%2C+Umber&rft.au=Mihindukulasuriya%2C+Kathie+A.&rft.date=2019-08-09&rft.pub=BioMed+Central&rft.eissn=1758-9193&rft.volume=11&rft_id=info:doi/10.1186%2Fs13195-019-0524-x&rft_id=info%3Apmid%2F31399126&rft.externalDocID=PMC6689177 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-9193&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-9193&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-9193&client=summon |